Femcinol-ADP Gel is a topical medication formulated with Adapalene 0.1% w/w and Clindamycin 1% w/w, designed for the treatment of acne vulgaris. Adapalene, a third-generation retinoid, works by modulating skin cell differentiation and keratinization, thereby preventing the formation of comedones and promoting the turnover of skin cells. Clindamycin, a lincosamide antibiotic, targets Propionibacterium acnes bacteria, reducing inflammation and bacterial proliferation within the hair follicles. The combination of these two active ingredients provides a dual mechanism of action, addressing both the inflammatory and non-inflammatory lesions of acne. Femcinol-ADP Gel is typically applied once daily to the affected areas after cleansing, and consistent use over several weeks is necessary to observe significant improvement. It is generally well tolerated, though some users may experience mild skin irritation, dryness, or redness during initial treatment. Patients are advised to avoid excessive sun exposure and use sunscreen while using this product. Femcinol-ADP Gel is suitable for individuals seeking an effective topical solution for mild to moderate acne, offering both antibacterial and comedolytic benefits in a single formulation.